Carcinoma, Ductal, Breast clinical trials at UC Health
1 research study open to eligible people
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
open to eligible females ages 18 years and up
Phase 2, open-label study of AVB-620 in women with primary, nonrecurrent and nonmetastatic breast cancer undergoing surgery.
at UCSD
Last updated: